IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib

A signaling pathway that is frequently deregulated in human carcinomas and has been explored as a therapeutic target involves the activation of the epidermal growth factor receptor (EGFR). Inhibition of EGFR via the small molecule inhibitors erlotinib and gefitinib commonly results in tumor resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Romaine I., Hamilton, Duane H., Dominguez, Charli, David, Justin M., McCampbell, Kristen K., Palena, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173114/
https://www.ncbi.nlm.nih.gov/pubmed/27248176
http://dx.doi.org/10.18632/oncotarget.9662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173114/
https://www.ncbi.nlm.nih.gov/pubmed/27248176
http://dx.doi.org/10.18632/oncotarget.9662

Ejemplares similares